comparemela.com

Latest Breaking News On - John vandermosten - Page 2 : comparemela.com

BioLineRx Ltd. (NASDAQ:BLRX) Q4 2023 Earnings Call Transcript

BioLineRx Ltd. (NASDAQ:BLRX) Q4 2023 Earnings Call Transcript March 26, 2024 BioLineRx Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Fourth Quarter and Full Year 2023 Financial […]

United-states
China
Mali
Gloria-biosciences
Phil-serlin
John-vandermosten
Columbia-university
Washington-university-school-of-medicine
Pancreatic-cancer
Washington-university-school
Kreos-capital
Lowest-fertility-rates

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states
Geneva
Genè
Switzerland
San-francisco
California
United-kingdom
Vancouver
British-columbia
Canada
British
John-vandermosten

Kineta to Present at the Life Sciences Investor Forum December 14th

SEATTLE, Dec. 12, 2023 Kineta, Inc. , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced.

Johnm-viglotti
John-mullaly
Jacques-bouchy
John-vandermosten
Shawn-iadonato
Cap-research
Linkedin
Corporate-services
Kineta-inc
Investor-relations-business-development
Nasdaq
Facebook

Kineta to Present at the Life Sciences Investor Forum

Kineta to Present at the Life Sciences Investor Forum
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Shawn-iadonato
John-vandermosten
Johnm-viglotti
Jacques-bouchy
John-mullaly
Nasdaq
Facebook
Lifesci-advisors
Life-science-investor-forum
Corporate-services
Cap-research
Linkedin

vimarsana © 2020. All Rights Reserved.